Chagas disease in immunocompromised patients.

Chagas disease Trypanosoma cruzi bone marrow transplantation human immunodeficiency virus immunocompromised hosts organ transplantation

Journal

Clinical microbiology reviews
ISSN: 1098-6618
Titre abrégé: Clin Microbiol Rev
Pays: United States
ID NLM: 8807282

Informations de publication

Date de publication:
28 Mar 2024
Historique:
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: aheadofprint

Résumé

SUMMARYAs Chagas disease remains prevalent in the Americas, it is important that healthcare professionals and researchers are aware of the screening, diagnosis, monitoring, and treatment recommendations for the populations of patients they care for and study. Management of

Identifiants

DOI: 10.1128/cmr.00099-23 PMID: 38546225
pubmed: 38546225
doi: 10.1128/cmr.00099-23
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009923

Auteurs

Eva H Clark (EH)

Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
ORCID: 0000-0002-0350-8753

Louisa A Messenger (LA)

Department of Environmental and Occupational Health, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
ORCID: 0000-0002-3107-6214

Jeffrey D Whitman (JD)

Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
ORCID: 0000-0002-3502-5799

Caryn Bern (C)

Department of Epidemiology and Biostatistics, University of California San Francisco School of Medicine, San Francisco, California, USA.
ORCID: 0000-0001-8195-7303

Classifications MeSH